Trending Now
TRACON Pharmaceuticals (NASDAQ:TCON): A Promising Contender in Cancer Therapeutics
As the biopharmaceutical landscape continues to evolve, TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a San Diego-based clinical-stage biopharmaceutical company, has emerged as...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Evofem Biosciences Inc (NASDAQ:EVFM) Posts A Net Loss Of $52.7 Million...
Evofem Biosciences Inc (NASDAQ:EVFM) widened its net loss to $52.7 million in Q2 2020 compared to $35.5 million in Q1 2020. The company reduced...
MAKE IT MODERN
LATEST REVIEWS
Viracta Therapeutics Inc. (NASDAQ: VIRX) Receives Orphan Drug Designation For Oral...
Viracta Therapeutics Inc. (NASDAQ: VIRX) has announced that the FDA has awarded its all-oral combination drug candidate nanatinostta and valganciclovir orphan drug designation for...
MAKE IT MODERN
PERFORMANCE TRAINING
Why Allied Energy (OTCMKTS:AGYP) Occupies a Potent Position in the Energy Patch
Allied Energy (OTCMKTS:AGYP) is a small-cap player in the energy space, but the company has an interesting angle on the production model...
Earnings Preview: Alphabet and AMD Gear Up for Key Financial Updates
Alphabet (GOOGL) Awaits Earnings Announcement Amidst AI Focus
Alphabet, the parent company of Google, is preparing to reveal its...
Mustang Bio Inc. (NASDAQ:MBIO) Enters Agreement With SIRION For LentiBOOST™ Tech And Starts Dosing...
Mustang Bio Inc. (NASDAQ:MBIO) has announced a license agreement with SIRION Biotech GmbH under which Mustang acquired rights to the LentiBOOST™ technology from SIRION....
Cyclacel Pharmaceuticals (NASDAQ: CYCC) Sees Significant Stock Volatility Amid New Financing Deal
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC), a prominent biopharmaceutical company focused on the development of innovative cancer therapies, recently witnessed significant stock price...
Seelos Therapeutics Inc. (NASDAQ:SEEL) Announce Commencement Of SLS-004 Preclinical Study In Parkinson’s Disease
Seelos Therapeutics Inc. (NASDAQ:SEEL) has announced the commencement of a preclinical SLS-004 study in Parkinson’s disease through a lentiviral vector that is all in...
MAKE IT MODERN
